Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Proposed origins of pelvic serous carcinoma include the ovary, fallopian tube, and peritoneum. Prophylactic salpingo-oophorectomies in BRCA+ women have recently identified the fimbria as a site of origin for early serous carcinoma (tubal intraepithelial carcinoma or TIC). We explored the relationship of TIC to pelvic serous carcinomas in consecutive cases with complete adnexal exam (SEE-FIM protocol). Cases positive (group A) or negative (group B) for endosalpinx (including fimbria) involvement, were subclassified as tubal, ovarian, or primary peritoneal in origin. Coexisting TIC was recorded in group A when present and p53 mutation status was determined in 5 cases. Of 55 evaluable cases, 41 (75%) were in group A; including tubal (n = 5), peritoneal (n = 6), and ovarian (n = 30) carcinomas. Foci of TIC were identified in 5 of 5, 4 of 6, and 20 of 30, respectively. Ninety-three percent of TICs involved the fimbriae. Five of 5 TICs and concurrent ovarian carcinomas contained identical p53 mutations. Thirteen of 14 cases in group B were classified as primary ovarian carcinomas, 10 with features supporting an origin in the ovary. Overall, 71% and 48% of "ovarian" serous carcinomas had endosalpinx involvement or TIC. TIC coexists with all forms of pelvic serous carcinoma and is a plausible origin for many of these tumors. Further studies are needed to elucidate the etiologic significance of TIC in pelvic serous carcinoma, reevaluate the criteria for tubal, peritoneal, and ovarian serous carcinoma, and define the role of the distal tube in pelvic serous carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Benedet, J. L. (2000) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(00)00300-3 · Cited by 1,104
Medeiros, F., Muto, M. G., Lee, Y., Elvin, J. A., Callahan, M. J., Feltmate, C., Garber, J. E., Cramer, D. W., & Crum, C. P. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180854.28831.77 · Cited by 916
Self-citationA candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 898
Self-citationA High Frequency of Sequence Alterations Is Due to Formalin Fixation of Archival Specimens
Williams, C., Pontén, F., Moberg, C., Söderkvist, P., Uhlén, M., Pontén, J., Sitbon, G., & Lundeberg, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65461-2 · Cited by 514
Singer, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.-F., Wang, T.-L., Kurman, R. J., & Shih, I.-M. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146025.91953.8d · Cited by 408 · cited 2×
“These include microsatellite instability and mutations in KRAS, BRAF, b-catenin, and pTEN.(26) The second group consists of serous carcinomas, which have 3 proposed origins, including the ovarian surface epithelium or mullerian inclusions, fallopian tube mucosa, and mullerian epithelium elsewhere in the peritoneal cav…”
BackgroundFinch, A., Shaw, P., Rosen, B., Murphy, J., Narod, S. A., & Colgan, T. J. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.06.065 · Cited by 375
Powell, C. B., Kenley, E., Chen, L.-M., Crawford, B., McLennan, J., Zaloudek, C., Komaromy, M., Beattie, M., & Ziegler, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.109 · Cited by 372
Colgan, T. J., Murphy, J., Cole, D. E. C., Narod, S., & Rosen, B. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200110000-00009 · Cited by 327
Pathology of ovarian cancer precursors
Scully, R. E. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590928 · Cited by 264
Plante, M., Rubin, S. C., Wong, G. Y., Federici, M. G., Finstad, C. L., & Gastl, G. A. (1994) · Cancer · doi:10.1002/1097-0142(19940401)73:7<1859::aid-cncr2820730714>3.0.co;2-l · Cited by 177
BRCA-Mutation–Associated Fallopian Tube Carcinoma: A Distinct Clinical Phenotype?
Cass, I., Holschneider, C., Datta, N., Barbuto, D., Walts, A. E., & Karlan, B. Y. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187892.78392.3f · Cited by 166
Lee, Y., Medeiros, F., Kindelberger, D. W., Callahan, M. J., Muto, M. G., & Crum, C. P. (2006) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000201826.46978.e5 · Cited by 162
Self-citationLocus-specific mutation databases: pitfalls and good practice based on the p53 experience
Soussi, T., Ishioka, C., Claustres, M., & Béroud, C. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1783 · Cited by 161
Endometrial Intraepithelial Carcinoma With Associated Peritoneal Carcinomatosis
Soslow, R. A., Pirog, E. C., & Isacson, C. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200005000-00012 · Cited by 137
Intraperitoneal serous adenocarcinoma: A critical appraisal of three hypotheses on its cause
Piek, J. M. J., Kenemans, P., & Verheijen, R. H. M. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.02.067 · Cited by 129
Schorge, J. O., Muto, M. G., Welch, W. R., Bandera, C. A., Rubin, S. C., Bell, D. A., Berkowitz, R. S., & Mok, S. C. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.841 · Cited by 129
Self-citationIncidence of malignant fallopian tube tumors
Rosenblatt, K. A., Weiss, N. S., & Schwartz, S. M. (1989) · Gynecologic Oncology · doi:10.1016/0090-8258(89)90051-6 · Cited by 124
Alvarado‐Cabrero, I., Navani, S. S., Young, R. H., & Scully, R. E. (1997) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199707000-00001 · Cited by 106
Age-specific ovarian cancer incidence rate patterns in the United States
Quirk, J. T., Natarajan, N., & Mettlin, C. J. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.06.052 · Cited by 78
Zheng, W., Li, N., Wang, J., Ulukus, E. C., Ulukus, M., Arici, A., & Liang, S. X. (2005) · International Journal of Gynecological Pathology · doi:10.1097/01.rct.0000157091.37057.b4 · Cited by 60
A BRIEF COMMUNICATION: DNA Damages in Ovarian Surface Epithelial Cells of Ovulatory Hens
Murdoch, W. J., Kirk, E. A. V., & Alexander, B. M. (2005) · Experimental Biology and Medicine · doi:10.1177/15353702-0323006-11 · Cited by 51
Körner, M., Burckhardt, E., & Mazzucchelli, L. (2005) · The Journal of Pathology · doi:10.1002/path.1817 · Cited by 27
(2000) · doi:10.1002/1097-0142(20000715)89:2
Cited by
Jayson, G. C., Kohn, E. C., Kitchener, H. C., & Ledermann, J. A. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62146-7 · Cited by 1,850
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I.-M. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,846
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
Epidemiology of ovarian cancer: a review
Brett M., R., Brett M., R., Jennifer B., P., Thomas A., S., Jennifer B., P., & Thomas A., S. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,524
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Bowtell, D. D., Böhm, S., Ahmed, A. A., Aspuria, P.-J., Bast, R. C., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S., Bookman, M. A., et al. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4019 · Cited by 1,367
Metadata
- Authors
- Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., Berkowitz, R. S., Muto, M. G., & Crum, C. P.
- Venue
- The American Journal of Surgical Pathology
- Published
- 2007-02
- Volume
- 31
- Issue
- 2
- Pages
- 161-169
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2056739417
- Cited by
- 1,113
- References
- 24
- FWCI
- 40.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.